GlassScriptPhysician profile
Kasey M Palm
NPI 1386038586
$2,484.25
in general payments reported to CMS, 2019-2025
14 companies · $14.50 in 2025
The $14.50 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $742 · 2021: $499 · 2022: $413 · 2023: $320 · 2024: $19.07 · 2025: $14.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $789.48 | 2019-2025 | Lynx System |
| Axonics, INC. | $525.98 | 2020-2023 | Axonics, Bulkamid |
| Medtronic USA, INC. | $468.69 | 2019-2020 | |
| Medtronic, INC. | $322.68 | 2021-2024 | Interstim, Nuro |
| Allergan, INC. | $114.14 | 2019 | |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Caldera Medical, INC | $30.27 | 2023 | Desara |
| Sumitomo Pharma America, INC. | $28.33 | 2023 | Gemtesa |
| Amgen INC. | $26.70 | 2020 | |
| Merz Pharmaceuticals, LLC | $23.43 | 2021 | |
| Dentsply Ih Ab | $14.52 | 2023 | Lofric |
| Meditrina | $14.14 | 2023 | |
| Dentsply Ih INC. | $14.05 | 2022 | |
| Checkpoint Surgical, INC | $11.85 | 2023 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kasey Palm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.